About

KRTL Holding Group (OTC: KRTL) serves as the parent company, providing strategic oversight and ensuring synergy among its subsidiaries. The group’s mission is to integrate innovation, regulatory excellence, and market expertise to deliver comprehensive solutions and drive sustainable growth.

​

KRTL Biotech Inc.

​

KRTL Biotech Inc, a wholly owned subsidiary of KRTL Holding Group (OTC: KRTL) and an FDA-registered pharmaceutical company, is dedicated to advancing biotechnology research and development. The company partners with cGMP manufacturers, ISO-certified laboratories, and academic institutions to foster innovation and deliver solutions across various sectors. Its commitment to quality and compliance makes it the foundation of KRTL’s operations and a leader in cutting-edge biotechnology.

​

KRTL International Inc.

​

KRTL International Inc, a wholly owned subsidiary of KRTL Holding Group (OTC: KRTL), is the distribution and consulting arm of the group. It bridges the gap between innovation and global markets by providing expert consulting services, strategic market analysis, and efficient distribution systems. This subsidiary ensures that KRTL’s products and solutions are tailored to client needs and delivered seamlessly worldwide.

​

Collaboration: A Unified Force

​

Together, KRTL Holding Group (OTC: KRTL), KRTL Biotech Inc, and KRTL International Inc form a cohesive and powerful team:

 

1. Leadership: KRTL Holding Group provides centralized strategy, aligning the subsidiaries to achieve shared goals.

2. Innovation: KRTL Biotech Inc develops cutting-edge, FDA-compliant biotech solutions through strategic partnerships with industry leaders.

3. Connection: KRTL International Inc ensures these innovations are distributed effectively and backed by consulting expertise.​

 

This unified approach enables KRTL Holding Group to deliver unmatched value, scale efficiently, and maintain a competitive edge in the biotechnology and consulting industries.